ERYTECH Responds to Akkadian’s Disinformation Post author:Cleo Sciscioli Post published:June 12, 2023 Post category:Newsroom The company reacts to a series of disinformation attempts by Akkadian Partners to try and destabilize ERYTECH. You Might Also Like ERYTECH Files Registration Statement for Proposed Initial Public Offering in the United States October 6, 2017 Webinar on Eryaspase in Pancreatic Cancer September 2, 2021 ERYTECH and PHERECYDES announce merger and name change to PHAXIAM Therapeutics June 26, 2023
ERYTECH Files Registration Statement for Proposed Initial Public Offering in the United States October 6, 2017